VERTEX PHARMACEUTICALS INC / MA (VRTX) Form 8-K — Oct 20, 2026
Vertex Pharmaceuticals appointed Daniel Brennan, former CFO of Boston Scientific, to its board of directors on October 20, 2026, expanding the board from ten to eleven members. Brennan also joined Vertex's Audit and Finance Committee and received a $400,000 restricted stock unit award vesting in October 2027. He brings extensive finance experience, including over a decade as Boston Scientific's CFO, and currently sits on the boards of Waters Corporation and Madrigal Pharmaceuticals.
Key figures
- Board size before
- 10
- Director rsua award usd
- 400000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.